Phillips-Medisize Corporation announces the completion of their Metal Injection Molding (MIM) facility expansion

February 16, 2016 (Hudson, Wisconsin) – Phillips-Medisize Corporation announced today the completion of their Metal Injection Molding (MIM) facility expansion. The now greater than 50,000 sq. ft. facility is located on the company’s Menomonie, Wisconsin medical campus. This is the second expansion of this site in the past three years to support continued growth of medical and specialty commercial business segments.

The greater than 50,000 sq. ft. facility, houses four continuous debind and sintering furnaces, multiple batch furnaces, dedicated metal injection molding equipment as well as a fully staffed and equipped metallurgical lab. The MIM process produces very complex parts with geometries and tightly controlled dimensional tolerances more cost effectively then casting or machining. The latest expansion adds continuous debind and sintering furnace capacity, which is more cost effective and provides a competitive advantage in the manufacturing of higher volume MIM components.

Matt Jennings, Chairman and CEO of Phillips-Medisize Corporation said, “We are very excited about this new expansion as it is yet another example of Phillips-Medisize’s continuous commitment to investing in our customers needs, as well as in keeping with our Company strategy of investing in people, processes and facilities. We believe this expansion, with the addition of another continuous debind and sintering furnace, also allows us to service more new, and existing, customers with the largest capacity for metal injection molding in North America.”

About Phillips-Medisize Corporation
Phillips-Medisize is a leading global outsource provider of design and manufacturing services to the drug delivery, consumable diagnostics and medical device, and specialty commercial markets. The company has annual sales of over $600 million with 80% of the total revenue coming from drug delivery, medical device, primary pharmaceutical packaging and diagnostic products such as: disposable insulin pens, glucose meters, specialty inhalation drug delivery devices, single use surgical devices and consumable diagnostic components.

Phillips-Medisize Corporation features a list of blue chip medical device, pharmaceutical and commercial customers. The company partners with its customers to provide design and development services which accelerate speed to market of innovative products and then works with its customers to deploy advanced automated assembly and quality control technologies which reduce manufacturing cost while improving quality. The company’s core advantage is the knowledge of its people to integrate design, molding, and automation to drive low cost and high quality manufacturing solutions.

Phillips-Medisize Corporation is headquartered in Hudson, WI, and employs over 3,400 people in 14 locations throughout the United States, Europe, Mexico and China. The company also has design centers in Wisconsin, California, The Netherlands and China.